Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02D Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial - Concepedia

Concepedia

Publication | Open Access

Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02D Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial

DOI Full Paper Access

43

Citations

18

References

2010

Year

Pedro Aíde, John J. Aponte, Montse Renom, Tacilta Nhampossa, Jahit Sacarlal, Inácio Mandomando, Quique Bassat, Maria Nélia Manaca, Amanda Leach, Marc Lievens,

Abstract

ClinicalTrials.gov NCT00197028.

References

	Year	Citations

Page 1